Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Astellas Pharma Inc
National Cancer Institute (NCI)
Eli Lilly and Company
Actuate Therapeutics Inc.
Novartis
Artios Pharma Ltd
University of California, San Francisco
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
AstraZeneca